AGILITY
Our best quality is fast response, fast delivery. A dedicated project manager will be always available for your needs.
Our best quality is fast response, fast delivery. A dedicated project manager will be always available for your needs.
Our best team will greet you, and the same team will handle your project. You entrust us with your most valuable project, and our finest scientists will make it happen.
Our pride is in understanding disease and your efforts to cure it. With more than 20 years of scientific experience, we will find you the right solution for your needs.
Atoxlab, Inc. was founded in 2017 with a vision to better the growth of young and dynamic Korean pharmaceutical and biotech industries. With more than 20 years of experience in biomedical sciences, we are rightly equipped in helping the industry finding cure for diseases and disorders.
In fact, we are very proud to see our clients succeeding in their drug development. Recent success stories by our clients in the application for IND (MFDS, FDA, and TGA) and clinical trials are the testament to our competency.
Process Development, Method Development and Validation, Formulation, Stability, DS/DP Manufacturing
In Vitro/In Vivo Models, ADME, PK, GLP Tox, DART, Carcinogenesis
Phase I, Phase IIa, PK Sample and Biomarker Analysis, Central Lab Services (CLIA)
IND submission, CTD Writing (MFDS, TGA, US FDA, EMA)
CEO : John Yi
Phone : 82-10-7189-2962
Email : john.yi@atoxlab.co.kr
109, Pangyoyeok-ro, Bundang-gu, Seongnam-si,
Gyeonggi-do, South Korea, 13531